Ischemic Post-Conditioning in a Rat Model of Asphyxial Cardiac Arrest

Cells. 2024 Jun 17;13(12):1047. doi: 10.3390/cells13121047.

Abstract

Background: Ischemic post-conditioning (IPoC) has been shown to improve outcomes in limited pre-clinical models. As down-time is often unknown, this technique needs to be investigated over a range of scenarios. As this tool limits reperfusion injury, there may be limited benefit or even harm after short arrest and limited ischemia-reperfusion injury.

Methods: Eighteen male Wistar rats underwent 7 min of asphyxial arrest. Animals randomized to IPoC received a 20 s pause followed by 20 s of compressions, repeated four times, initiated 40 s into cardiopulmonary resuscitation. If return of spontaneous circulation (ROSC) was achieved, epinephrine was titrated to mean arterial pressure (MAP) of 70 mmHg. Data were analyzed using t-test or Mann-Whitney test. Significance set at p ≤ 0.05.

Results: The rate of ROSC was equivalent in both groups, 88%. There was no statistically significant difference in time to ROSC, epinephrine required post ROSC, carotid flow, or peak lactate at any timepoint. There was a significantly elevated MAP with IPoC, 90.7 mmHg (SD 13.9), as compared to standard CPR, 76.7 mmHg (8.5), 2 h after ROSC, p = 0.03.

Conclusions: IPoC demonstrated no harm in a model of short arrest using a new arrest etiology for CPR based IPoC intervention in a rat model.

Keywords: advanced cardiac life support; asphyxia; basic life support; cardiopulmonary resuscitation; compressions; ischemia-reperfusion injury; murine; resuscitation.

Publication types

  • Research Support, U.S. Gov't, Non-P.H.S.
  • Research Support, Non-U.S. Gov't
  • Research Support, N.I.H., Extramural

MeSH terms

  • Animals
  • Asphyxia* / complications
  • Cardiopulmonary Resuscitation / methods
  • Disease Models, Animal*
  • Epinephrine
  • Heart Arrest* / complications
  • Heart Arrest* / physiopathology
  • Heart Arrest* / therapy
  • Ischemic Postconditioning* / methods
  • Male
  • Rats
  • Rats, Wistar*

Substances

  • Epinephrine